Day Zero Diagnostics
Clinical pathology trainee with expertise in microbiology and immunology. After a biomedical engineering degree at MIT, studied immunology on a Rhodes Scholarship in Oxford and in the Harvard MD-PhD Program. Residency and Medical Microbiology fellowship at MGH.
This person is not in any offices
Day Zero Diagnostics
The future of infectious disease diagnostics starts at Day Zero. By using whole-genome sequencing (WGS) and the proprietary enabling technologies, Day Zero is creating a new class of sequencing-based in-vitro diagnostics that generates clinically actionable data at scale.